Small Lymphocytic Lymphoma (SLL) Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +7 more
  • Manchester, United Kingdom
    The Christie NHS Foundation Trust
2022-03-15
Mar 15, 2022
N
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Duarte, California
  • +10 more
2022-03-25
Mar 25, 2022
M
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Venetoclax monotherapy
  • Venetoclax with anti CD20 monoclonal antibody
  • Basking Ridge, New Jersey
  • +9 more
2022-03-15
Mar 15, 2022
B
Recruiting
  • Mantle Cell Lymphoma
  • +9 more
  • L-Bcl-2 antisense oligonucleotide
  • Augusta, Georgia
  • +2 more
2022-03-08
Mar 8, 2022
U
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Rochester, New York
    University of Rochester
2022-02-07
Feb 7, 2022
A
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Concord, New South Wales, Australia
  • +30 more
2022-01-31
Jan 31, 2022
E
Not yet recruiting
  • Non-Hodgkin's Lymphoma (NHL)
  • +4 more
  • (no location specified)
2022-01-24
Jan 24, 2022
M
Recruiting
  • Follicular Lymphoma (FL)
  • +6 more
  • Duarte, California
  • +10 more
2022-01-18
Jan 18, 2022
N
Active, not recruiting
  • Safety and Tolerability
  • +3 more
  • Zoster Vaccine Recombinant, Adjuvanted
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-01-10
Jan 10, 2022
A
Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
2022-01-12
Jan 12, 2022
M
Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
2021-12-14
Dec 14, 2021
C
Enrolling by invitation
  • Relapsed/Refractory B-cell Lymphomas
  • +8 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
2021-11-30
Nov 30, 2021
C
Recruiting
  • Relapsed/Refractory B-cell Lymphomas
  • +8 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
2021-11-30
Nov 30, 2021
A
Completed
  • Non-Hodgkin Lymphoma (NHL)
  • +4 more
  • Nagoya shi, Aichi, Japan
  • +13 more
2021-07-29
Jul 29, 2021
A
Active, not recruiting
  • Follicular Lymphoma (FL)
  • +12 more
  • Tucson, Arizona
  • +18 more
2021-06-17
Jun 17, 2021
U
Withdrawn
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Bendamustine and Rituximab Induction followed by Rituximab and Lenalidomide Maintenance
  • (no location specified)
2019-11-13
Nov 13, 2019
N
Unknown status
  • Chronic Lymphocytic Leukemia (CLL)
  • +2 more
  • Nanjing, Jiangsu, China
  • +1 more
2019-04-27
Apr 27, 2019
G
Terminated
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +5 more
2018-10-19
Oct 19, 2018
G
Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • La Jolla, California
  • +2 more
2015-03-19
Mar 19, 2015